Watch Ticker

Bristol-Myers Squibb Company Contingent Value Rights

Go to Bristol-Myers Squibb Company Contingent Value Rights Website

$0.03

0.00 (0.00%)

Live

Previous Close

$0.0301

Day Range

$0.0301 - $0.0301

Previous Day Range

$0.0301 - $0.0301

Market Cap

$ USD

Day Vol.

2158

Previous Day Vol.

738

Currency

USD

Primary Exchange

New York Stock Exchange

...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Researchandmarkets.Com - Testicular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer

Global testicular cancer market is evolving with emerging trends in personalized therapies, immunotherapy, and fertility preservation, driven by key pharmaceutical companies focusing on innovative treatment approaches.

Related tickers: PFE, MRK, RHHBY, BMY, CELGr, LLY.

Read Full Article

Delveinsight - Adrenocortical Carcinoma Market Forecast upto 2034—Insights into Emerging Therapies and Market Trends | DelveInsight

The adrenocortical carcinoma market is expected to grow from USD 30 million in 2024, driven by emerging therapies and increasing ACC cases. Key emerging treatments include CY-101 and OR-449, with several pharmaceutical companies exploring innovative approaches to treating this rare cancer.

Related tickers: GSK, BMY, CELGr, MRK.

Read Full Article

Trending Tickers

Please sign in to view